semaglutide weight loss creve coeur Physician-led, primary care–based GLP-1 in St. Louis Semaglutide cardiovascular outcomes align more

To book your appointment, you can fill out our online contact form, check our Price Simulator, or call (425) 775-3561

Some clinicians prescribe based on the insulin resistance and metabolic dysfunction itself, but insurance coverage may not follow

The median follow-up was only 47 days, too short for most patients to lose enough weight to meaningfully alter their levothyroxine requirements through the weight-based mechanism alone

Mounjaro (tirzepatide) : Mounjaro is an injectable medication approved for the treatment of Type 2 diabetes and increasingly prescribed off-label for weight loss due to its potent dual action on both GLP-1 and GIP receptors